(NASDAQ:COGT), — Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria — — Bezuclastinib demonstrated a powerful effect on mast cell burden with 89% of patients achieving greater-than or equal to50% reduction in bone marrow mast cells […]

(NASDAQ:GEMI), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) today announced that Marshall Beard, Chief Operating Officer, and Dan Chen, Chief Financial Officer, will attend the Goldman Sachs 2025 Financial Services Conference on December 9, 2025. Management will be available for one-on-one and small group investor meetings. Channels

(NASDAQ:ABEO), CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a first-of-its-kind, autologous gene therapy for treating wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). ZEVASKYN was administered at Lucile Packard Children's Hospital Stanford in Palo

(NYSE:GTN),(NYSE:GTN-A), ATLANTA, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today it entered into purchase agreements (the “Purchase Agreements”) with certain accredited investors (collectively, the “Investors”), pursuant to which Gray agreed to sell to the investors, in a private placement transaction (the “Offering”), $250 million aggregate principal amount of 9.625%

(NASDAQ:DFLI),(NASDAQ:DFLIW), RENO, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries(R), today announced that World Cat, the world's largest producer of power catamarans, has expanded its integration of Battle Born(R) power systems across new

(NASDAQ:SYBT), LOUISVILLE, Ky., Dec. 08, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky markets, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that William J. Otten will be promoted

(NYSE MKT:PHGE), Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011, its phage program for Staphylococcus aureus (S. aureus) infections associated with diabetic foot infections (DFI). The Company is also implementing cost cutting measures,

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss GlobeNewswire December 08, 2025 Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks GlobeNewswire December 08, 2025 REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12

Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results GlobeNewswire December 08, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that it has sold approximately 4.1 million shares of Class A Common Stock of Ryan Specialty Holdings, Inc.